Please try another search
For the nine months ended 31 March 2011, PharmaRoth Labs Inc revenues increased from $0K to $200K. Net loss increased from $15K to $383K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Professional fees increase from $0K to $210K (expense), Interest expense increase from $0K to $8K (expense).
Period Ending: | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 |
---|---|---|---|---|
Total Revenue | 0.2 | 124.82 | 0 | 0 |
Gross Profit | 0.08 | 21.66 | ||
Operating Income | -0.1 | -401.22 | -0.22 | -0.25 |
Net Income | -0.1 | -389.56 | -0.22 | -0.25 |
Period Ending: | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 |
---|---|---|---|---|
Total Assets | 0.09 | 1897.66 | 0.03 | 0 |
Total Liabilities | 0.39 | 2212.77 | 0.33 | 0.29 |
Total Equity | -0.3 | -315.11 | -0.31 | -0.29 |
Period Ending: | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.15 | -518.44 | -0.03 | -0.02 |
Cash From Investing Activities | 4.54 | |||
Cash From Financing Activities | 0.15 | 522.07 | 0.03 | 0.02 |
Net Change in Cash | 0 | 6.76 | 0 | 0 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review